Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Mighty Kingdom’s largest shareholder warns of bankruptcy, demands Chairperson’s removal at upcoming AGM
    • News

    Mighty Kingdom’s largest shareholder warns of bankruptcy, demands Chairperson’s removal at upcoming AGM

    In a story-line fit for a video game, gaming company Mighty Kingdom (ASX: MKL) is set for a drama-packed AGM on November 29 with the Company’s largest shareholder Shane Yeend utilising his massive social network to highlight Mighty Kingdom’s dire financial situation in order to have current Chairperson, Michelle Guthrie, ousted.  In a LinkedIn post

    Read More
    Public
  • Vitura receives first MDMA for its newly-minted psychedelics arm Cortexa
    • News

    Vitura receives first MDMA for its newly-minted psychedelics arm Cortexa

    In May 2023, diversified digital health company Vitura Health (ASX: VIT) announced a joint venture with Canadian psychedelic company PharmAla Biotech, giving birth to its Melbourne-based psychedelics arm, Cortexa. Providing an update on the 50-50 venture, the Company has noted an “Australian first” win. Its MDMA bulk GMP (good manufacturing practice) Active Pharmaceutical Ingredient (API)

    Read More
    Public
  • Parkway partners with Energy Estate to boost sustainability initiatives in Queensland
    • News

    Parkway partners with Energy Estate to boost sustainability initiatives in Queensland

    Aussie CleanTech company Parkway Corporate (ASX: PWN) and Australian clean energy development firm Energy Estate have entered into a strategic partnership to advance sustainability initiatives in regional Queensland. The partnership seeks to leverage the strengths of both organisations to address several vital opportunities. Key focus areas include renewable energy, green chemicals, and waste disposal, with

    Read More
    Public
  • Can our market shake off the rate rise?
    • Market Update

    Can our market shake off the rate rise?

    The XJO is expected to open flat this morning following another small rise in the U.S overnight. Yesterday the RBA raised the cash rate by 25 basis point from 4.1% to 4.35%. The statement was rather wishy-washy, but indicated that they feel we have seen peak inflation and that it would be likely unnecessary to

    Read More
    Public
  • Island Pharmaceuticals receives ethics approval for Dengue fever drug
    • News

    Island Pharmaceuticals receives ethics approval for Dengue fever drug

    The world could soon be one step closer to a preventative for Dengue fever with Island Pharmaceuticals (ASX: ILA), an Australian antiviral drug development company obtaining Human Research Ethics Committee (HREC) approval to initiate its human trials for drug ISLA-101.  This step of the regulatory approval framework is a significant step forward in the Company’s

    Read More
    Public
  • Markets get caught by a triple surprise | Economic Update
    • News

    Markets get caught by a triple surprise | Economic Update

    Interest Rates The markets were caught by a triple surprise last week. Firstly, the Treasury opted to issue less 10 and 30-year bonds and more 3-5 year bonds for its refinancing, then the ISM manufacturing and services PMI data was weaker, and finally the non-farm payrolls were weaker than expected. This brought about what looks

    Read More
    Public
  • «
  • ‹
  • 156
  • 157
  • 158
  • 159
  • 160
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.